Skip to main content
Clinical Trials/ISRCTN13384956
ISRCTN13384956
Active, not recruiting
未知

Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care

Intensive Care National Audit & Research Centre (ICNARC)0 sites16,500 target enrollmentDecember 8, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Invasive ventilation in intensive care
Sponsor
Intensive Care National Audit & Research Centre (ICNARC)
Enrollment
16500
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38737312/ (added 08/07/2024)

Registry
who.int
Start Date
December 8, 2020
End Date
February 28, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Intensive Care National Audit & Research Centre (ICNARC)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18 years
  • 2\. Receiving invasive mechanical ventilation in the ICU following an unplanned ICU admission (i.e. not admitted after an elective procedure) OR invasive mechanical ventilation started in the ICU (i.e. the patient was intubated in the ICU)
  • 3\. Receiving supplemental oxygen (fractional inspired concentration of oxygen (FiO2\) \>0\.21\) at the time of enrolment

Exclusion Criteria

  • 1\. Previously randomised into UK\-ROX in the last 90 days
  • 2\. The clinician considers that one study treatment arm is either indicated or contraindicated.
  • Removed 20/04/2021:
  • A data dictionary will contain relevant examples of conditions where clinicians may exclude patients (at their discretion) because conservative oxygen therapy is either indicated or contraindicated (e.g. chronic lung diseases, receiving hyperbaric oxygen, prior bleomycin exposure, carbon monoxide poisoning).
  • Added 22/02/2021:
  • 3\. Currently receiving extracorporeal membrane oxygenation (ECMO)

Outcomes

Primary Outcomes

Not specified

Similar Trials